Lineage Foundation for Good Celebrates One-Year Anniversary, Announces “Holidays for Good” Campaign
Lineage Foundation for Good (the “Foundation”), the independent philanthropic arm of Lineage Logistics, LLC (“Lineage”), recently celebrated its one-year anniversary. The nonprofit, which aims to redirect food that would otherwise go to waste and address hunger to support the social and economic mobility of our communities, has successfully donated the equivalent of 239 million meals over the past two years.
“Given recent events, global hunger and food insecurity is rising, affecting more than 800 million people,” said Christine Rees-Zecha, Board President of the Lineage Foundation for Good. “Through the Lineage Foundation for Good, we aim to leverage our network, expertise, and partnerships to prevent waste and redirect food into the communities that need it most. While there is still more work to do, I am proud of the accomplishments we achieved in the first year, including delivering more than 200 million meals to those in need, made possible by our dedicated team members.”
Last October, Lineage launched the Lineage Foundation for Good following the Company’s successful inaugural campaign, which provided 100 million meals to people in need during the height of the pandemic. In addition to supporting Lineage’s philanthropic efforts, the Foundation has sought to strengthen initiatives and organizations that align with the Company’s mission to create innovative and sustainable solutions to help reduce food waste and fight food insecurity.
At its inception, the Foundation set a goal to donate the equivalent of 500 million meals to people in need by 2025. To date, it is on track to significantly exceed this goal. As the Foundation continues to make progress on this commitment, it has also achieved notable progress in the following areas:
- Raised over $234,000 to support the Global FoodBanking Network and the Polish Humanitarian Action Organization’s efforts in response to the ongoing conflict in Ukraine.
- Supported Lineage team members and their families impacted by the conflict who returned to Ukraine to assist by continuing to pay their wages, as well as providing stipends to team members who are housing refugees and covered the relocation costs of five families.
- Contributed over 1,000 volunteer hours in communities worldwide, such as volunteering at food banks and distributing meals at community-based kitchens.
- Issued more than $1.6 million in community-based grants to local food banks, schools and other community-based organizations to help with operational costs.
- Donated over $600,000 to the Team Member Hardship Grant program, an initiative dedicated to financially supporting Lineage team members through times of hardship.
- In partnership with Penske, Darden Foundation, supported the donation of 10 refrigerated trucks to Feeding America® member food banks.
- Received a historic one-million-pound donation that will benefit six food banks within the Feeding America network.
- Grew its global network of partnerships to 50 strategic partners, which includes the Global FoodBanking Network, Feeding America, Empowerment Plan, Move for Hunger and the Darden Foundation. Through these partnerships, the Foundation has coordinated volunteer events and made charitable donations to partners.
“Over the past year, we’ve partnered with the Lineage Foundation for Good on their mission to reduce food waste and address food insecurity,” said Diane Letson, vice president of food industry partnerships at Feeding America. “With nearly 34 million people facing hunger in America, and amid the challenging inflationary environment many are experiencing, we are grateful for the recent work that Lineage and its partners accomplished in diverting one million pounds of food from going to waste and ensuring that it reached our neighbors in need.”
Building on the momentum of a successful first year, the Foundation is also launching the “Holidays for Good” Campaign to donate food to local communities during the holiday season. Beginning in November and running through the holiday season, “Holidays for Good” will contribute the equivalent of one million meals through customer product donations, food drives and volunteer events that benefit local community food banks.
For more information on the Lineage Foundation for Good, visit the Foundation page here. You can also reach out to foundation@lineagelogistics.com for information on partnership opportunities, volunteer events, and other ways to support.
About Lineage Foundation for Good
The Lineage Foundation for Good (the “Foundation”) is the independent philanthropic arm of Lineage Logistics, LLC (“Lineage”). The Foundation leverages the unique access, influence, experience, and expertise of Lineage, one of the world’s largest temperature-controlled logistics solutions providers, and its customers and partners to reduce food waste and fight food insecurity – a need that was accelerated by the practical challenges of getting quality food to those in need during the COVID-19 pandemic. Central to the Foundation’s mission is to develop a dynamic, real-time, and global link between those who commercially produce our food and the individuals, families, and communities who need it most. The Foundation creates a system in which food products, including those that might have otherwise gone to waste, can be quickly and easily steered to food pantries and other non-profits combatting food insecurity around the world. The Foundation supports various philanthropic initiatives that have an impact in the communities in which we live and work, and is proud to partner with Feeding America, the Global FoodBanking Network, and other organizations to expand its reach, maximize its impact, and help feed the world.
About Lineage Logistics
Lineage Logistics is the world’s largest temperature-controlled industrial REIT and logistics solutions provider. It has a global network of over 400 strategically located facilities totaling over 2 billion cubic feet of capacity, which spans 20 countries across North America, Europe, and Asia-Pacific. Lineage’s industry-leading expertise in end-to-end logistical solutions, its unrivaled real estate network and the development and deployment of innovative technology help increase distribution efficiency, advance sustainability, minimize supply chain waste, and, most importantly, as a Visionary Partner of Feeding America, help feed the world. In recognition of the company’s leading innovations and sustainability initiatives, Lineage was a 2022 U.S. Best Managed Company, No. 3 in the 2022 CNBC Disruptor 50 list, No. 17 in the 2021 CNBC Disruptor 50 list, the No 1. Data Science company, and 23rd overall, on Fast Company’s 2019 list of The World’s Most Innovative Companies, in addition to being included on Fortune’s Change The World list in 2020. (www.lineagelogistics.com)
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221116005327/en/
Contact information
Lineage Logistics
Christina Wiese
734-608-1855
cwiese@lineagelogistics.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 05:37:00 EET | Press release
Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the National Institute of Standards and Technology (NIST) show that many commercial facial recognition algorithms have significantly higher error rates for women and people of colour largely due to underrepresentation in datasets AI algorithms are trained on. Biased algorithms lead to unfair denials of service and create security vulnerabilities. The competition at the Conference on Neural Information Processing Systems, among the world’s most prestigious AI con
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 01:00:00 EET | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemia (CLL), highlighting the foundational potential of this medicine. “The data we’re presenting at ASH 2025 are redefining what physicians can expect from sonrotoclax as a next-generation BCL2 inhibitor,” said Amit Agarwal, M.D., Ph.D., Chief Medical
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release
Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
